(XUCD) Xtrackers MSCI USA Consumer - Ratings and Ratios
Consumer Goods, Services, Retail, Leisure, Automobiles
Description: XUCD Xtrackers MSCI USA Consumer
The Xtrackers MSCI USA Consumer Discretionary UCITS ETF (XUCD) is a sector-specific exchange-traded fund that focuses on the consumer discretionary segment of the US market. The fund tracks a composite index, comprising 50% MSCI World Consumer Discretionary and 50% MSCI World Consumer Staples, both in net return currency.
As a Sector Equity Consumer Goods & Services ETF, XUCD provides investors with exposure to companies in the US consumer discretionary sector, which includes industries such as automobiles, hotels, restaurants, and leisure. The funds underlying index is likely to be dominated by large-cap stocks, given the MSCI USA indexs market-capitalization-weighted methodology.
To evaluate the funds performance, we can consider key performance indicators (KPIs) such as tracking error, expense ratio, and dividend yield. A low tracking error would indicate that the fund is effectively replicating its underlying index. The expense ratio, which is not provided, is also crucial in determining the funds net returns. Additionally, the dividend yield, which can be estimated based on the underlying holdings, is an important consideration for income-seeking investors.
From a technical analysis perspective, the funds price action can be assessed using various indicators. While the provided technical data indicates a relatively stable price trend, with the short-term moving averages (SMA20 and SMA50) above the current price, the long-term SMA200 is above the current price, suggesting a potential resistance level. Furthermore, the Average True Range (ATR) of 1.06 (1.39%) indicates moderate volatility, which may be relevant for investors with specific risk tolerance.
With an Assets Under Management (AUM) of approximately 439.92 million EUR, XUCD appears to have a reasonable scale, which can contribute to liquidity and potentially lower trading costs. However, investors should consider other factors, such as the funds trading volume, bid-ask spread, and market maker activity, to ensure that it meets their investment requirements.
Additional Sources for XUCD ETF
XUCD ETF Overview
Market Cap in USD | 514m |
Category | Sector Equity Consumer Goods & Services |
TER | 0.12% |
IPO / Inception | 2017-09-12 |
XUCD ETF Ratings
Growth Rating | 49.1 |
Fundamental | - |
Dividend Rating | 26.3 |
Rel. Strength | 1.18 |
Analysts | - |
Fair Price Momentum | 72.23 EUR |
Fair Price DCF | - |
XUCD Dividends
Dividend Yield 12m | 0.46% |
Yield on Cost 5y | 0.79% |
Annual Growth 5y | 2.06% |
Payout Consistency | 90.8% |
Payout Ratio | % |
XUCD Growth Ratios
Growth Correlation 3m | 40.6% |
Growth Correlation 12m | 33.4% |
Growth Correlation 5y | 67.3% |
CAGR 5y | 11.47% |
CAGR/Max DD 5y | 0.30 |
Sharpe Ratio 12m | 0.91 |
Alpha | 0.57 |
Beta | 0.822 |
Volatility | 16.22% |
Current Volume | 0.3k |
Average Volume 20d | 0.7k |
Stop Loss | 74.9 (-3%) |
As of July 16, 2025, the stock is trading at EUR 77.24 with a total of 325 shares traded.
Over the past week, the price has changed by +2.24%, over one month by +2.92%, over three months by +14.65% and over the past year by +9.33%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers MSCI USA Consumer (XETRA:XUCD) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 49.06 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XUCD is around 72.23 EUR . This means that XUCD is currently overvalued and has a potential downside of -6.49%.
Xtrackers MSCI USA Consumer has no consensus analysts rating.
According to our own proprietary Forecast Model, XUCD Xtrackers MSCI USA Consumer will be worth about 82.5 in July 2026. The stock is currently trading at 77.24. This means that the stock has a potential upside of +6.81%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 82.5 | 6.8% |